Free Trial

Upstream Bio (UPB) News Today

Upstream Bio logo
$8.64 0.00 (-0.05%)
As of 01:52 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Upstream Bio, Inc. stock logo
Samsara BioCapital LLC Acquires Shares of 2,217,146 Upstream Bio, Inc. (NASDAQ:UPB)
Samsara BioCapital LLC bought a new position in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,217,146 shares of the company's stock, valued at approximately $36,450,000.
Upstream Bio, Inc. stock logo
Soros Fund Management LLC Makes New Investment in Upstream Bio, Inc. (NASDAQ:UPB)
Soros Fund Management LLC bought a new stake in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 46,350 shares of the company's stock, valued at approximatel
Upstream Bio, Inc. stock logo
TCG Crossover Management LLC Takes $44.86 Million Position in Upstream Bio, Inc. (NASDAQ:UPB)
TCG Crossover Management LLC bought a new position in shares of Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,801,763 shares of the company's stock, valued at
Upstream Bio, Inc. stock logo
Nantahala Capital Management LLC Acquires Shares of 600,000 Upstream Bio, Inc. (NASDAQ:UPB)
Nantahala Capital Management LLC purchased a new stake in shares of Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 600,000 shares of the company's s
Upstream Bio, Inc. stock logo
JPMorgan Chase & Co. Acquires Shares of 47,792 Upstream Bio, Inc. (NASDAQ:UPB)
JPMorgan Chase & Co. purchased a new stake in shares of Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 47,792 shares of the company's stock, valued at approximate
Upstream Bio, Inc. stock logo
Lynx1 Capital Management LP Makes New Investment in Upstream Bio, Inc. (NASDAQ:UPB)
Lynx1 Capital Management LP purchased a new stake in shares of Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 240,042 shares of the company's stock, valued at approximately $3,946,000.
Upstream Bio, Inc. stock logo
Decheng Capital LLC Buys Shares of 3,285,293 Upstream Bio, Inc. (NASDAQ:UPB)
Decheng Capital LLC acquired a new position in shares of Upstream Bio, Inc. (NASDAQ:UPB - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 3,285,293 shares of the company's stock, valued at approximately $54,010,000. Upst
Upstream Bio, Inc. stock logo
Geode Capital Management LLC Purchases New Position in Upstream Bio, Inc. (NASDAQ:UPB)
Geode Capital Management LLC purchased a new position in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 363,269 shares of the company's stock, valued at approximately
Upstream Bio, Inc. stock logo
Marshall Wace LLP Makes New $4.78 Million Investment in Upstream Bio, Inc. (NASDAQ:UPB)
Marshall Wace LLP purchased a new stake in shares of Upstream Bio, Inc. (NASDAQ:UPB - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 290,734 shares of the company's stock, valued at approximat
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Trading 7.2% Higher - Here's What Happened
Upstream Bio (NASDAQ:UPB) Trading 7.2% Higher - Should You Buy?
Upstream Bio, Inc. stock logo
Bain Capital Life Sciences Investors LLC Acquires New Holdings in Upstream Bio, Inc. (NASDAQ:UPB)
Bain Capital Life Sciences Investors LLC purchased a new stake in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 2,295,322 shares of the
Upstream Bio, Inc. stock logo
Fmr LLC Purchases New Position in Upstream Bio, Inc. (NASDAQ:UPB)
Fmr LLC acquired a new position in shares of Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 7,176,187 shares of the company's stock, valued at approximately $117,977,000. Fmr LLC owned
Upstream Bio, Inc. stock logo
Alliancebernstein L.P. Invests $18.27 Million in Upstream Bio, Inc. (NASDAQ:UPB)
Alliancebernstein L.P. bought a new stake in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,111,337 shares of the company's stock, valued at approxim
Upstream Bio, Inc. stock logo
Wellington Management Group LLP Makes New $25.63 Million Investment in Upstream Bio, Inc. (NASDAQ:UPB)
Wellington Management Group LLP bought a new stake in shares of Upstream Bio, Inc. (NASDAQ:UPB - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,583,154 shares of the company's stock, valued at approxi
Upstream Bio, Inc. stock logo
Norges Bank Invests $16.44 Million in Upstream Bio, Inc. (NASDAQ:UPB)
Norges Bank acquired a new stake in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,000,000 shares of the company's stock, valued at approximately $16,440,000. Norge
Upstream Bio, Inc. stock logo
Upstream Bio, Inc.'s Lock-Up Period Will Expire on April 9th (NASDAQ:UPB)
Upstream Bio's (NASDAQ:UPB - Get Free Report) lock-up period is set to end on Wednesday, April 9th. Upstream Bio had issued 15,000,000 shares in its IPO on October 11th. The total size of the offering was $255,000,000 based on an initial share price of $17.00. After the expiration of Upstream Bio's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.
Upstream Bio, Inc. stock logo
Charles Schwab Investment Management Inc. Invests $2.23 Million in Upstream Bio, Inc. (NASDAQ:UPB)
Charles Schwab Investment Management Inc. bought a new stake in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 135,323 shares of the company's stock, valued at approxima
Upstream Bio, Inc. stock logo
Bank of New York Mellon Corp Invests $607,000 in Upstream Bio, Inc. (NASDAQ:UPB)
Bank of New York Mellon Corp purchased a new stake in shares of Upstream Bio, Inc. (NASDAQ:UPB - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 36,913 shares of the company's stock, valued at approximatel
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Stock Price Down 7.3% - Time to Sell?
Upstream Bio (NASDAQ:UPB) Trading Down 7.3% - Time to Sell?
Upstream Bio, Inc. stock logo
William Blair Forecasts Increased Earnings for Upstream Bio
Upstream Bio, Inc. (NASDAQ:UPB - Free Report) - Stock analysts at William Blair upped their Q1 2025 EPS estimates for shares of Upstream Bio in a research note issued to investors on Wednesday, March 12th. William Blair analyst M. Phipps now forecasts that the company will post earnings per share
UPB Upstream Bio, Inc.
Piper Sandler Remains a Buy on Upstream Bio, Inc. (UPB)
Upstream Bio, Inc. stock logo
Upstream Bio (UPB) Projected to Post Earnings on Thursday
Upstream Bio (NASDAQ:UPB) will be releasing earnings before the market opens on Thursday, February 27, Financial Modeling Prep reports.
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Reaches New 1-Year Low - What's Next?
Upstream Bio (NASDAQ:UPB) Hits New 12-Month Low - Here's What Happened
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Trading Down 7.3% - Time to Sell?
Upstream Bio (NASDAQ:UPB) Stock Price Down 7.3% - Time to Sell?
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Stock Price Up 9.4% - Here's What Happened
Upstream Bio (NASDAQ:UPB) Stock Price Up 9.4% - Time to Buy?
Upstream Bio, Inc. stock logo
Moody Aldrich Partners LLC Makes New Investment in Upstream Bio, Inc. (NASDAQ:UPB)
Moody Aldrich Partners LLC purchased a new stake in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 74,773 shares of the company's stock, valued at approximately $1,229,000. Moody Aldrich Partners
Upstream Bio, Inc. (UPB)
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Hits New 52-Week Low - Time to Sell?
Upstream Bio (NASDAQ:UPB) Sets New 52-Week Low - Here's Why
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Shares Down 3.9% - Here's What Happened
Upstream Bio (NASDAQ:UPB) Shares Down 3.9% - Here's Why
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Shares Down 10.4% - Here's Why
Upstream Bio (NASDAQ:UPB) Trading Down 10.4% - Here's Why
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Reaches New 12-Month Low - Should You Sell?
Upstream Bio (NASDAQ:UPB) Reaches New 12-Month Low - Should You Sell?
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Shares Down 7% - Should You Sell?
Upstream Bio (NASDAQ:UPB) Shares Down 7% - Time to Sell?
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Trading 8.5% Higher - Still a Buy?
Upstream Bio (NASDAQ:UPB) Trading Up 8.5% - What's Next?
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Trading Down 3% - Here's What Happened
Upstream Bio (NASDAQ:UPB) Trading Down 3% - Here's What Happened
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Shares Up 5.7% - Time to Buy?
Upstream Bio (NASDAQ:UPB) Stock Price Up 5.7% - Still a Buy?
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Reaches New 52-Week Low - Should You Sell?
Upstream Bio (NASDAQ:UPB) Reaches New 12-Month Low - What's Next?
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Shares Gap Down - Should You Sell?
Upstream Bio (NASDAQ:UPB) Shares Gap Down - Should You Sell?
Upstream Bio Appoints Allison Ambrose as General Counsel
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Shares Down 5% - Time to Sell?
Upstream Bio (NASDAQ:UPB) Stock Price Down 5% - What's Next?
Upstream Bio to join Russell 2000 index
Upstream Bio Announces Addition to Russell 2000® Index
Get Upstream Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPB and its competitors with MarketBeat's FREE daily newsletter.

UPB Media Mentions By Week

UPB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

UPB
News Sentiment

1.77

0.72

Average
Medical
News Sentiment

UPB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

UPB Articles
This Week

6

2

UPB Articles
Average Week

Get Upstream Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:UPB) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners